2000
DOI: 10.1006/jmbi.2000.4095
|View full text |Cite
|
Sign up to set email alerts
|

II. Structure and specificity of the interaction between the FHA2 domain of rad53 and phosphotyrosyl peptides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
55
0

Year Published

2000
2000
2008
2008

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 52 publications
(56 citation statements)
references
References 34 publications
(53 reference statements)
1
55
0
Order By: Relevance
“…Three phosphopeptides were used to examine the affinities of the four FHA mutants for phosphopeptides: SLEV(pT)EADATFVQ (peptide I), EVEL(pT)QELP (peptide II), and EDI(pY)YLD (peptide III, a phosphotyrosine peptide). All three phosphopeptides correspond to partial sequences of Rad9, a potential binding partner of the FHA1 and FHA2 domains (7,18,19). The structures of the FHA1-peptide I, FHA2-peptide II, and FHA2-peptide III complexes have all been determined by NMR in our laboratory, and their binding properties have been characterized (7,(18)(19)(20).…”
Section: Resultsmentioning
confidence: 99%
“…Three phosphopeptides were used to examine the affinities of the four FHA mutants for phosphopeptides: SLEV(pT)EADATFVQ (peptide I), EVEL(pT)QELP (peptide II), and EDI(pY)YLD (peptide III, a phosphotyrosine peptide). All three phosphopeptides correspond to partial sequences of Rad9, a potential binding partner of the FHA1 and FHA2 domains (7,18,19). The structures of the FHA1-peptide I, FHA2-peptide II, and FHA2-peptide III complexes have all been determined by NMR in our laboratory, and their binding properties have been characterized (7,(18)(19)(20).…”
Section: Resultsmentioning
confidence: 99%
“…Extracts from these cells were immunoblotted for Chfr after treatment with lambda phosphatase (PPase) or buffer, as described in Materials and methods ubiquitin-conjugating enzymes (Joazeiro et al, 1999;Levkowitz et al, 1999;Lorick et al, 1999;Ciechanover et al, 2000;Zheng et al, 2000). Second, Chfr has an FHA domain, a type of domain involved in proteinprotein interactions (Durocher et al, 1999(Durocher et al, , 2000Liao et al, 1999;Wang et al, 2000;Stavridi et al, 2002). Ubiquitin ligases typically contain protein-protein interaction domains to recognize their substrates.…”
Section: Discussionmentioning
confidence: 99%
“…At its N-terminus, Chfr has a forkhead-associated (FHA) domain. FHA domains from other proteins bind phosphopeptides (Durocher et al, 1999(Durocher et al, , 2000Liao et al, 1999;Wang et al, 2000). The three-dimensional structure of the Chfr FHA domain bound to tungstate, an analog of phosphate, suggests that Chfr also recognizes phosphorylated proteins (Stavridi et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…These are the only FHA domains whose tertiary structures have been determined in the free form. 5,8,9 Despite relatively low sequence homology, they are structurally similar, consisting mainly of antiparallel b-sheets that fold into a twisted bsandwich. Signi®cant differences, however, are noticeable in some of the elements (turns, loops, and a-helix) that connect 11 structurally equivalent b-strands.…”
Section: Introductionmentioning
confidence: 99%
“…The FHA2 domain has been demonstrated to bind both pY-peptides 5,9 and pTpeptides. 10,11 For FHA1, a consensus ligand motif of pTXXD has been identi®ed, where Asp is required at the 3 position and Ala/Ile is preferred at the 2 position for high-af®nity recognition.…”
Section: Introductionmentioning
confidence: 99%